Doktorgradsavhandling

• Tina Fonnes; Camilla Krakstad (2018). Preclinical models and molecular biomarkers. Tools to improve treatment in endometrial carcinoma. (ekstern lenke)
• Mari Kyllesø Halle; Helga Salvesen; Camilla Krakstad (2017). Molecular alterations suggesting new treatment strategies in uterine carcinomas. (ekstern lenke)
• Ingvild Løberg Tangen; Helga Salvesen; Camilla Krakstad (2016). Hormone signaling related factors as biomarkers in endometrial cancer. (ekstern lenke)
• Camilla Krakstad (2005). The role of CaMKII and cA-PK in control of cell survival and death. (ekstern lenke)

Konferanseabstrakt

• Ingvild Løberg Tangen; Camilla Krakstad; Henrica Maria Johanna Werner et al. (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. (ekstern lenke)
• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (ekstern lenke)
• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (ekstern lenke)

Konferanseforedrag

• Camilla Krakstad; Anne Elisabeth Christensen; Stein Ove Døskeland (2004). cAMP protects neutrophils against TNFa-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (ekstern lenke)
• Camilla Krakstad (2004). cAMP protects neutrophils against TNF_-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (ekstern lenke)
• Camilla Krakstad (2004). Apoptotic phenotypes induced by natural toxins - Okadaic Acid acts by short-circuiting an ancient irradiation induced death pathway. (ekstern lenke)
• Reidun Kopperud; Camilla Krakstad; Frode Selheim et al. (2003). cAMP effector mechanisms. Novel twists for an "old" signalling system. (ekstern lenke)
• Camilla Krakstad; Anne Elisabeth Christensen; Stein Ove Døskeland (2002). cAMP protects neutrophils against TNF_-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (ekstern lenke)
• Camilla Krakstad; Stein Ove Døskeland (2001). Cell death in HeLa cells. (ekstern lenke)
• Stein Ove Døskeland; Kari Espolin Fladmark; Camilla Krakstad et al. (1998). Distinct apoptotic death forms. Distinct pathways and functions?. (ekstern lenke)

Konferanseposter

• Lars Herfindal; Lene Elisabeth Myhren; Rune Kleppe et al. (2010). Liver specific transporters of microcystins as a tool to find novel inhibitors of OATP1B1 and OATP1B3. (ekstern lenke)
• Tone Sandal; Camilla Krakstad; Nina Ånensen et al. (2003). Myeloid leukemia cell differentiation by bcl-2 and camp involves induction of ccaat/enhancer binding protein ? (c/ebp?), nuclear accumulation of c/ebp?, and direct interaction between bcl-2 and c/ebp?. (ekstern lenke)
• Lars Herfindal; Frode Selheim; Kjetil Aursland et al. (2002). Effects of a new bioactive substance from a marine microalga on mammalian cells. (ekstern lenke)
• Lars Herfindal; Camilla Krakstad; Frode Selheim et al. (2001). TWO NOVEL APOPTOSIS-MODULATION SUBSTANCES ISOLATED FROM MARINE MICRO-ALGAE. (ekstern lenke)

Leserbrev

• Stephanie W Vrede; Vit Weinberger; Eva Colas et al. (2025). It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer. (ekstern lenke)
• Mari Kyllesø Halle; Henrica Maria Johanna Werner; Camilla Krakstad et al. (2012). Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. (ekstern lenke)

Masteroppgave

• Frode Selheim; Camilla Krakstad; Even Birkeland (2008). Quantitative proteomics of Epac signaling in differentiating human SH-SY5Y neuroblastoma cells. (ekstern lenke)
• Marie Louise Ljones; Camilla Krakstad; Frode Selheim (2008). Epac-induced neuronal differentiation of Human SH-SY5Y neuroblastoma cells. (ekstern lenke)
• Lise Fismen; Kari Espolin Fladmark; Camilla Krakstad (2005). Role of Cu/Zn superoxide dismutase (SOD1) in phosphatase inhibitor-induced apoptosis. (ekstern lenke)

Rettelse i tidsskrift

• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (ekstern lenke)
• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (ekstern lenke)

Vitenskapelig artikkel

• Mari Kyllesø Halle; Janka Babickova; Hege Fredriksen Berg et al. (2026). Discordance in molecular classification of primary and metastatic endometrial cancer: implications for precision treatment. (ekstern lenke)
• Kristine Eldevik Fasmer; Sunniva Lindås; Ankush Gulati et al. (2026). Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods. (ekstern lenke)
• Tobias M.P. Hartwich; Seungji Choi; Ayoung Hwang et al. (2026). Integrated mutational landscape analysis of endometrial stromal sarcoma. (ekstern lenke)
• Marike S. Lombaers; Casper Reijnen; Ally Sprik et al. (2025). ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment. (ekstern lenke)
• Marit Louise Ulvang; Oda Vik Fløtre; Hege Fredriksen Berg et al. (2025). Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions. (ekstern lenke)
• Kristine Eldevik Fasmer; Ankush Gulati; Sunniva Lindås et al. (2025). Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [18F]FDG PET primary tumor radiomics. (ekstern lenke)
• Kristine Eldevik Fasmer; Jostein Sæterstøl; Maria Beate Svanes Ljunggren et al. (2025). Abdominal fat distribution in endometrial cancer: from diagnosis to follow-up. (ekstern lenke)
• Marta Brunetti; Valeria Vitelli; Anca Michaela Naas et al. (2025). Molecular Landscape of Endometrial Stromal Tumors. (ekstern lenke)
• Heidi Espedal; Jenny Margrethe Lyngstad; Hege Fredriksen Berg et al. (2025). Evaluation of early chemotherapy response by combining static- and dynamic [¹⁸F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models. (ekstern lenke)
• Kristina Yvonne Kathe Lindemann; Franziska Siegenthaler; Karin Teien Johannesen et al. (2025). Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study. (ekstern lenke)
• Njål Lura; Kari Strøno Wagner-Larsen; Stian Torkildson Ryste et al. (2025). Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer. (ekstern lenke)
• Kari Strøno Wagner-Larsen; Njål Lura; Ankush Gulati et al. (2025). MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer. (ekstern lenke)
• Hege Fredriksen Berg; Jone Trovik; Marta Espevold Hjelmeland et al. (2025). Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining. (ekstern lenke)
• Hilde Eide Lien; Marta Espevold Hjelmeland; Hege Fredriksen Berg et al. (2025). Multiplex single-cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer. (ekstern lenke)
• Puk Meijs-Hermanns; Henrica Maria Johanna Werner; Loes Kooreman et al. (2025). Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma. (ekstern lenke)
• Mari Kyllesø Halle; Erlend Hodneland; Kari Strøno Wagner-Larsen et al. (2024). Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer. (ekstern lenke)
• Marta Espevold Hjelmeland; Hilde Eide Lien; Hege Fredriksen Berg et al. (2024). Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer. (ekstern lenke)
• Erlend Hodneland; Erling Andersen; Kari Strøno Wagner-Larsen et al. (2024). Impact of MRI radiomic feature normalization for prognostic modelling in uterine endometrial and cervical cancers. (ekstern lenke)
• Maartje M. W. Luijten; Willem Jan van Weelden; Roy I. Lalisang et al. (2024). Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma. (ekstern lenke)
• Mari Kyllesø Halle; Olivera Bozickovic; David Erik Forsse et al. (2024). Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer. (ekstern lenke)
• Madeleine Charlotte van der Berg; Hege Fredriksen Berg; Tomasz Stokowy et al. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (ekstern lenke)
• Stefania Bellone; Kyungjo Jeong; Mari Kyllesø Halle et al. (2024). Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix. (ekstern lenke)
• Heidi Espedal; Kristine Eldevik Fasmer; Hege Fredriksen Berg et al. (2024). MRI radiomics captures early treatment response in patient-derived organoid endometrial cancer mouse models. (ekstern lenke)
• Camilla Krakstad; Hege Fredriksen Berg; Kristina Yvonne Kathe Lindemann et al. (2024). Frequency of ERBB2-Low Expression in Endometrial Cancer. (ekstern lenke)
• Cecilie Fredvik Torkildsen; Liv Cecilie Vestrheim Thomsen; Ragnar Sande et al. (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. (ekstern lenke)
• Marike S. Lombaers; Karlijn M. C. Cornel; Nicole C. M. Visser et al. (2023). Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer. (ekstern lenke)
• Kari Strøno Wagner-Larsen; Erlend Hodneland; Kristine Eldevik Fasmer et al. (2023). MRI-based radiomic signatures for pretreatment prognostication in cervical cancer. (ekstern lenke)
• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (ekstern lenke)
• Hanna Kosberg Bredin; Camilla Krakstad; Erling André Høivik (2023). PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. (ekstern lenke)
• Agnes Jørgensen Eide; Mari Kyllesø Halle; Njål Lura et al. (2023). Visceral fat percentage for prediction of outcome in uterine cervical cancer. (ekstern lenke)
• Erlend Hodneland; Sathiesh Kumar Kaliyugarasan; Kari Strøno Wagner-Larsen et al. (2022). Fully Automatic Whole-Volume Tumor Segmentation in Cervical Cancer. (ekstern lenke)
• Hege Fredriksen Berg; Hilde Renate Engerud; Madeleine Myrvold et al. (2022). Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. (ekstern lenke)
• Kari Strøno Wagner-Larsen; Njål Gjærde Lura; Øyvind Salvesen et al. (2022). Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer. (ekstern lenke)
• Njål Gjærde Lura; Kari Strøno Wagner-Larsen; David Erik Forsse et al. (2022). What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?. (ekstern lenke)
• Julie Andrea Dybvik; Kristine Eldevik Fasmer; Sigmund Ytre-Hauge et al. (2022). MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. (ekstern lenke)
• Kristine Eldevik Fasmer; Ankush Gulati; Julie Andrea Dybvik et al. (2022). Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?. (ekstern lenke)
• Nigar Sofiyeva; Camilla Krakstad; Mari Kyllesø Halle et al. (2022). APOBEC3A/B deletion polymorphism and endometrial cancer risk. (ekstern lenke)
• Ankur Chakravarthy; Ian Reddin; Stephen Henderson et al. (2022). Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. (ekstern lenke)
• Fiona J. Ruiz; Aishwarya Sundaresan; Jin Zhang et al. (2021). Genomic characterization and therapeutic targeting of HPV undetected cervical carcinomas. (ekstern lenke)
• Willem Jan van Weelden; Casper Reijnen; Heidi V.N. Küsters-Vandevelde et al. (2021). The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study. (ekstern lenke)
• Tina Fonnes; Ingrid Ovidia Moe Telle; David Erik Forsse et al. (2021). Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers. (ekstern lenke)
• David Erik Forsse; Mark Lewis B Barbero Barbero; Henrica Maria Johanna Werner et al. (2021). Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study. (ekstern lenke)
• Willem Jan van Weelden; Roy I Lalisang; Johan Bulten et al. (2021). Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer. (ekstern lenke)
• Fatemeh Mazloumi Gavgani; Thomas Karlsson; Ingvild Løberg Tangen et al. (2021). Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells. (ekstern lenke)
• Mari Kyllesø Halle; Ane Cecilie Dæhli Munk; Birgit Øvstebø Engesæter et al. (2021). A gene signature identifying CIN3 regression and cervical cancer survival. (ekstern lenke)
• Heidi Espedal; Hege Fredriksen Berg; Tina Fonnes et al. (2021). Feasibility and utility of MRI and dynamic 18F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer. (ekstern lenke)
• Mari Kyllesø Halle; Marte Sødal; David Erik Forsse et al. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (ekstern lenke)
• Erling Andre Høivik; Erlend Hodneland; Julie Andrea Dybvik et al. (2021). A radiogenomics application for prognostic profiling of endometrial cancer. (ekstern lenke)
• S.W. Vrede; Willem Jan van Weelden; Nicole C.M. Visser et al. (2021). Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. (ekstern lenke)
• Irene Tveiterås Øvestad; Birgit Øvstebø Engesæter; Mari Kyllesø Halle et al. (2021). High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling. (ekstern lenke)
• Erlend Hodneland; Julie Andrea Dybvik; Kari Strøno Wagner-Larsen et al. (2021). Automated segmentation of endometrial cancer on MR images using deep learning. (ekstern lenke)
• Havjin Jacob; Julie Andrea Dybvik; Sigmund Ytre-Hauge et al. (2021). An mri-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer. (ekstern lenke)
• Frederic Amant; W. Glenn Mccluggage; Henrica Maria Johanna Werner et al. (2021). Incorporating molecular profiling into endometrial cancer management requires prospective studies. (ekstern lenke)
• Mari Kyllesø Halle; Aishwarya Sundaresan; Jianqing Zhang et al. (2021). Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.. (ekstern lenke)
• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (ekstern lenke)
• Hilde Renate Engerud; Hege Fredriksen Berg; Madeleine Myrvold et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (ekstern lenke)
• Hege Fredriksen Berg; Zhenlin Ju; Madeleine Myrvold et al. (2020). Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. (ekstern lenke)
• Kristine Eldevik Fasmer; Ankush Gulati; Julie Andrea Dybvik et al. (2020). Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. (ekstern lenke)
• Tina Fonnes; Elin Strand; Kristine Eldevik Fasmer et al. (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. (ekstern lenke)
• Casper Reijnen; Evangelia Gogou; Nicole C.M. Visser et al. (2020). Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. (ekstern lenke)
• Sigmund Ytre-Hauge; Øyvind Salvesen; Camilla Krakstad et al. (2020). Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. (ekstern lenke)
• Eric Mörth; Kari Strøno Wagner-Larsen; Erlend Hodneland et al. (2020). RadEx: Integrated visual exploration of multiparametric studies for radiomic tumor profiling. (ekstern lenke)
• David Erik Forsse; Hege Fredriksen Berg; Olivera Bozickovic et al. (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. (ekstern lenke)
• Kristine Eldevik Fasmer; Erlend Hodneland; Julie Andrea Dybvik et al. (2020). Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. (ekstern lenke)
• Frederik Holst; Henrica Maria Johanna Werner; Siv Mjøs et al. (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. (ekstern lenke)
• David Erik Forsse; Ingvild Løberg Tangen; Kristine Eldevik Fasmer et al. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. (ekstern lenke)
• Casper Reijnen; Willem Jan van Weelden; Martijn S.J.P. Arts et al. (2019). Poor outcome in hypoxic endometrial carcinoma is related to vascular density. (ekstern lenke)
• Elin Strand; Ingvild Løberg Tangen; Kristine Eldevik Fasmer et al. (2019). Blood metabolites associate with prognosis in endometrial cancer. (ekstern lenke)
• Nicole C.M. Visser; Louis J.M. van der Putten; Alex van Egerschot et al. (2019). Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study. (ekstern lenke)
• Hilde Renate Engerud; Kirsten Øvergaard Hope; Hege Fredriksen Berg et al. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. (ekstern lenke)
• Gro Vatne Røsland; Sissel Elisabeth Dyrstad; Deusdedit Tusubira et al. (2019). Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC.. (ekstern lenke)
• Willem Jan van Weelden; Kristine Eldevik Fasmer; Ingvild Løberg Tangen et al. (2019). Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: A retrospective study. (ekstern lenke)
• Gonda F.J. Konings; Niina Saarinen; Bert Delvoux et al. (2018). Development of an image-guided orthotopic xenograft mouse model of endometrial cancer with controllable estrogen exposure. (ekstern lenke)
• Madalene Earp; Jonathan P. Tyrer; Stacey J. Winham et al. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. (ekstern lenke)
• Mac Versluis; Annechien Plat; Marco de Bruyn et al. (2018). L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. (ekstern lenke)
• Kanthida Kusonmano; Mari Kyllesø Halle; Elisabeth Wik et al. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. (ekstern lenke)
• Linda E. Kelemen; Madalene Earp; Brooke L. Fridley et al. (2018). rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology. (ekstern lenke)
• Vikram Rao Bollineni; Sigmund Ytre-Hauge; Ankush Gulati et al. (2018). The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients. (ekstern lenke)
• Gonda F.J. Konings; Karlijn M.C. Cornel; Sofia Xanthoulea et al. (2018). Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach. (ekstern lenke)
• Ingvild Løberg Tangen; Kristine Eldevik Fasmer; Gonda F Konings et al. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. (ekstern lenke)
• Jodie N. Painter; Tracy A. O'Mara; Andrew P. Morris et al. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. (ekstern lenke)
• Kristine Eldevik Fasmer; Atle Bjørnerud; Sigmund Ytre-Hauge et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (ekstern lenke)
• Tracy A. O'Mara; Dylan M. Glubb; Frédéric Amant et al. (2018). Identification of nine new susceptibility loci for endometrial cancer. (ekstern lenke)
• Tina Fonnes; Jone Trovik; Per-Henrik D. Edqvist et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (ekstern lenke)
• Sigmund Ytre-Hauge; Julie Andrea Dybvik; Arvid Lundervold et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (ekstern lenke)
• Mari Kyllesø Halle; Akinyemi I Ojesina; Hilde Renate Engerud et al. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (ekstern lenke)
• Reidun Kristin Kopperud; Cecilie Brekke Rygh; Tine Veronica Karlsen et al. (2017). Increased microvascular permeability in mice lacking Epac1 (Rapgef3). (ekstern lenke)
• Karen Klepsland Mauland; Zhenlin Ju; Ingvild Løberg Tangen et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (ekstern lenke)
• Thomas Karlsson; Camilla Krakstad; Ingvild Løberg Tangen et al. (2017). Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation. (ekstern lenke)
• Mari Kyllesø Halle; Ingvild Løberg Tangen; Hege Fredriksen Berg et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (ekstern lenke)
• Tina Fonnes; Hege Fredriksen Berg; Therese Bredholt Onyango et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (ekstern lenke)
• Nuria Eritja; Mariona Jove; Kristine Eldevik Fasmer et al. (2017). Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. (ekstern lenke)
• Anna Berg; Ankush Gulati; Sigmund Ytre-Hauge et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (ekstern lenke)
• Nicole C.M. Visser; Henrica Maria Johanna Werner; Camilla Krakstad et al. (2017). Type of vascular invasion in association with progress of endometrial cancer. (ekstern lenke)
• Ingvild Løberg Tangen; Reidun Kristin Kopperud; Nicole C.M. Visser et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (ekstern lenke)
• Sigmund Ytre-Hauge; Morteza Esmaeili; Torill Eidhammer Sjøbakk et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (ekstern lenke)
• Ingvild Løberg Tangen; Jennifer Taylor Venereis; Mari Kyllesø Halle et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (ekstern lenke)
• Karen Klepsland Mauland; Øyvin Andre Solberg Eng; Sigmund Ytre-Hauge et al. (2017). High visceral fat percentage is associated with poor outcome in endometrial cancer. (ekstern lenke)
• Siv Mjøs; Henrica Maria Johanna Werner; Even Birkeland et al. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. (ekstern lenke)
• Shalaka S. Hampras; Lara E. Sucheston-Campbell; Rikki Cannioto et al. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. (ekstern lenke)
• William J. Gibson; Erling Andre Høivik; Mari Kyllesø Halle et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (ekstern lenke)
• Ingvild Løberg Tangen; Therese Bredholt Onyango; Reidun Kristin Kopperud et al. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. (ekstern lenke)
• Karen Klepsland Mauland; Elisabeth Wik; Erling Andre Høivik et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (ekstern lenke)
• KM Cornel; Camilla Krakstad; B Delvoux et al. (2016). High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer. (ekstern lenke)
• Alice W Lee; Claire Templeman; Douglas A Stram et al. (2016). Evidence of a genetic link between endometriosis and ovarian cancer. (ekstern lenke)
• Anna Berg; Kristine Eldevik Fasmer; Karen Klepsland Mauland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (ekstern lenke)
• Linda E. Kelemen; Kate Lawrenson; Jonathan Tyrer et al. (2015). Genome-wide significant risk associations for mucinous ovarian carcinoma. (ekstern lenke)
• Alice W. Lee; Jonathan P Tyrer; Jennifer A Doherty et al. (2015). Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study. (ekstern lenke)
• Kate Lawrenson; Edwin S. Iversen; Jonathan Tyrer et al. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (ekstern lenke)
• Ingfrid S. Haldorsen; Mihaela Lucia Popa; Tina Fonnes et al. (2015). Multimodal imaging of orthotopic mouse model of endometrial carcinoma. (ekstern lenke)
• Ganna Chornokur; Hui-Yi Lin; Jonathan P. Tyrer et al. (2015). Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. (ekstern lenke)
• Anna Berg; Erling Andre Høivik; Siv Mjøs et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (ekstern lenke)
• Siddhartha P. Kar; Jonathan P. Tyrer; Qiyuan Li et al. (2015). Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. (ekstern lenke)
• Camilla Krakstad; Ingvild Løberg Tangen; Erling Andre Høivik et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (ekstern lenke)
• Shannon N. Westin; Zhenlin Ju; Russell R. Broaddus et al. (2015). PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients. (ekstern lenke)
• Per-Henrik D. Edqvist; Jutta Huvila; Björn Forsström et al. (2015). Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma. (ekstern lenke)
• Kate Lawrenson; Qiyuan Li; Siddhartha Kar et al. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. (ekstern lenke)
• Ernest K. Amankwah; Hui-Yi Lin; Jonathan P. Tyrer et al. (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. (ekstern lenke)
• Lorena Alonso-Alconada; Maria Santacana; Pablo Garcia-Sanz et al. (2015). Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. (ekstern lenke)
• Karoline B. Kuchenbäcker; Susan J. Ramus; Jonathan Tyrer et al. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. (ekstern lenke)
• Erling Andre Høivik; Kanthida Kusonmano; Mari Kyllesø Halle et al. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. (ekstern lenke)
• Henrica Maria Johanna Werner; Jone Trovik; Mari Kyllesø Halle et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (ekstern lenke)
• Ingvild Løberg Tangen; Henrica Maria Johanna Werner; Anna Berg et al. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. (ekstern lenke)
• Mari Kyllesø Halle; Camilla Krakstad; Hilde Renate Haugen Engerud et al. (2014). Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix. (ekstern lenke)
• Akinyemi Ojesina; Lee Lichtenstein; Samuel S. Freeman et al. (2014). Landscape of genomic alterations in cervical carcinomas. (ekstern lenke)
• Lorena Alonso-Alconada; Laura Muinelo-Romay; Kadri Madissoo et al. (2014). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. (ekstern lenke)
• Lars Herfindal; Camilla Krakstad; Lene Elisabeth Myhren et al. (2014). Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3. (ekstern lenke)
• Linda E. Kelemen; Kathryn L. Terry; Marc T. Goodman et al. (2014). Consortium analysis of diet-gene interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.. (ekstern lenke)
• Bridget Charbonneau; MS Block; WR Bamlet et al. (2014). Risk of ovarian cancer and the NF-kB pathway: Genetic association with IL1A and TNFSF10. (ekstern lenke)
• Elisabeth Wik; Jone Trovik; Kanthida Kusonmano et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (ekstern lenke)
• Hilde Renate Haugen Engerud; Ingvild Løberg Tangen; Ansgar Berg et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (ekstern lenke)
• Ingvild Løberg Tangen; Camilla Krakstad; Mari Kyllesø Halle et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (ekstern lenke)
• Stig E. Bojesen; Karen A Pooley; Sharon E Johnatty et al. (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. (ekstern lenke)
• Henrica Maria Johanna Werner; Anna Berg; Elisabeth Wik et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (ekstern lenke)
• Lars Herfindal; Gyrid Nygaard; Reidun Kristin Kopperud et al. (2013). Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets. (ekstern lenke)
• Hui Shen; BL Fridley; HL Song et al. (2013). Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. (ekstern lenke)
• Jennifer Permuth-Wey; K Lawrenson; HC Shen et al. (2013). Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. (ekstern lenke)
• Paul D.P. Pharoah; Mari Kyllesø Halle; Camilla Krakstad et al. (2013). GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. (ekstern lenke)
• Elisabeth Wik; Even Birkeland; Jone Trovik et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (ekstern lenke)
• Elisabeth Wik; Maria B Ræder; Camilla Krakstad et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (ekstern lenke)
• Jone Trovik; Elisabeth Wik; Henrica Maria Johanna Werner et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (ekstern lenke)
• Maria B Ræder; Even Birkeland; Jone Trovik et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (ekstern lenke)
• Ryan J. Delahanty; Yong-Bing Xiang; Amanda Spurdle et al. (2013). Polymorphisms in inflammation pathway genes and endometrial cancer risk. (ekstern lenke)
• Camilla Krakstad; Jone Trovik; Elisabeth Wik et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (ekstern lenke)
• Camilla Krakstad; Even Birkeland; Danila Seidel et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. (ekstern lenke)
• Even Birkeland; Elisabeth Wik; Siv Mjøs et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (ekstern lenke)
• Jirong Long; Wei Zheng; Yong-Bing Xiang et al. (2012). Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. (ekstern lenke)
• Sjur Huseby; Gro Gausdal; Thomas Jeffrey Keen et al. (2011). Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. (ekstern lenke)
• Lars Herfindal; Lene Elisabeth Myhren; Rune Kleppe et al. (2011). Nostocyclopeptide-M1: A potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and 1B1. (ekstern lenke)
• Even Birkeland; G Nygaard; Eystein Oveland et al. (2009). Epac-induced Alterations in the Proteome of Human SH-SY5Y Neuroblastoma Cells. (ekstern lenke)
• Gro Gausdal; Bjørn Tore Gjertsen; Emmet Martin McCormack et al. (2008). Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death. (ekstern lenke)
• Martha Chekenya; Camilla Krakstad; Agnete Svendsen et al. (2008). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. (ekstern lenke)
• Camilla Krakstad; Lars Herfindal; Bjørn Tore Gjertsen et al. (2006). CaM-kinasell-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. (ekstern lenke)
• Camilla Krakstad; Anne Elisabeth Christensen; Stein Ove Døskeland (2004). cAMP protects neutrophils against TNF?-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac). (ekstern lenke)
• Karl Johan Tronstad; Bjørn Tore Gjertsen; Camilla Krakstad et al. (2003). Mitochondrial-targeted fatty acid analog induces apoptosis with selective loss of mitochondrial glutathione in promyelocytic leukemia cells. (ekstern lenke)
• Reidun Kopperud; Camilla Krakstad; Frode Selheim et al. (2003). cAMP effector mechanisms. Novel twists for an "old" signaling system. (ekstern lenke)
• Kari Espolin Fladmark; Odd Terje Brustugun; Gunnar Mellgren et al. (2002). Ca2+/calmodulin dependent protein kinase II is required for microcystin-induced apoptosis. (ekstern lenke)

Vitenskapelig bokkapittel

• Helga Birgitte Salvesen; Henrica Maria Johanna Werner; Camilla Krakstad (2013). PI3K Pathway in Gynecologic Malignancies. (ekstern lenke)
• Gro Gausdal; Camilla Krakstad; Lars Herfindal et al. (2007). Serine/Threonine Protein Phosphatases in Apoptosis. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Jenneke C. Kasius; Johanna M. A. Pijnenborg; Kristina Lindemann et al. (2021). Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. (ekstern lenke)
• Eva Baxter; Donal J. Brennan; Jessica N. McAlpine et al. (2020). Improving response to progestin treatment of low-grade endometrial cancer. (ekstern lenke)
• Andreas Obermair; Eva Baxter; Donal J. Brennan et al. (2020). Fertility-sparing treatment in early endometrial cancer: Current state and future strategies. (ekstern lenke)
• Heidi Espedal; Tina Fonnes; Kristine Eldevik Fasmer et al. (2019). Imaging of preclinical endometrial cancer models for monitoring tumor progression and response to targeted therapy. (ekstern lenke)
• Cristian P. Moiola; Carlos Lopez-Gil; Silvia Cabrera et al. (2018). Patient-derived xenograft models for endometrial cancer research. (ekstern lenke)
• Fatemeh Mazloumi Gavgani; Victoria Smith Arnesen; Rhian Gaenor Jacobsen et al. (2018). Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer. (ekstern lenke)
• Antoinette Hollestelle; Frederieke H Van Der Baan; Andrew Berchuck et al. (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (ekstern lenke)
• Rune Kleppe; Camilla Krakstad; Frode Selheim et al. (2011). The cAMP-dependent protein kinase pathway as therapeutic target - possibilities and pitfalls. (ekstern lenke)
• Camilla Krakstad; Martha Chekenya (2010). Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.